Immunomodulators and immunosuppressants for myasthenia gravis: a network meta-analysis.

IF 8.8 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cochrane Database of Systematic Reviews Pub Date : 2025-06-04 DOI:10.1002/14651858.CD016208

Lucia B Varela, Nicolás Meza, Camila Micaela Escobar Liquitay, Samanta Díaz Menai, Juan Franco, Luis Garegnani

引用次数: 0

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary To assess the comparative benefits and harms of immunomodulators and immunosuppressants for people with generalised myasthenia gravis through a network meta-analysis. Secondary To estimate the relative ranking of immunomodulators and immunosuppressants according to their effects.

查看原文本刊更多论文

重症肌无力的免疫调节剂和免疫抑制剂：网络荟萃分析。

目的：这是Cochrane综述（干预）的一个方案。目的如下：主要通过网络荟萃分析评估免疫调节剂和免疫抑制剂对全身性重症肌无力患者的比较利弊。次级根据免疫调节剂和免疫抑制剂的作用来估计它们的相对排名。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cochrane Database of Systematic Reviews 医学-医学：内科

CiteScore

10.60

自引率

2.40%

发文量

173

审稿时长

1-2 weeks

期刊介绍： The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.